Stocktoria
Xeris Biopharma Holdings, Inc. XERS
Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2018-06-21
Xeris Biopharma Holdings, Inc. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| D. E. Shaw & Co., Inc. | 7,788,811 | $45.2M | 4.51% |
| BlackRock Finance, Inc. | 10,332,078 | $23.2M | 5.98% |
| MILLENNIUM MANAGEMENT LLC | 2,265,974 | $13.1M | 1.31% |
| TWO SIGMA INVESTMENTS, LP | 1,924,202 | $11.2M | 1.11% |
| AQR CAPITAL MANAGEMENT LLC | 1,394,376 | $8.1M | 0.81% |
| CITADEL ADVISORS LLC | 747,234 | $4.3M | 0.43% |
| RENAISSANCE TECHNOLOGIES LLC | 452,860 | $2.6M | 0.26% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.